BioCardia, Inc.
BCDADrugs in Pipeline
1
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Autologous cell therapy | Phase 3 | Heart Failure, Systolic | - | - |
Frequently asked questions
What is in BioCardia, Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in BioCardia, Inc.'s (BCDA) pipeline across Phase 3. Its lead program is Autologous cell therapy (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is BioCardia, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for BioCardia, Inc. (BCDA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track BCDA biotech catalysts?→
Add BCDA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow BioCardia, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.